CBU
AMRX icon

CIBC Bancorp USA’s Amneal Pharmaceuticals AMRX Stock Holding History

CIBC Bancorp USA’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$161K Buy
+16,041
New +$144K ﹤0.01% 1306

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CIBC Bancorp USA's AMRX Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2025: 16,041 shares worth $161K. The stake represents ﹤0.01% of the portfolio and ranks #1306 among its holdings.

248 funds tracked by Wall St. Rank hold AMRX as of Q3 2025.

  • CIBC Bancorp USA held 16,041 shares of Amneal Pharmaceuticals worth $161K as of Q3 2025.
  • Amneal Pharmaceuticals was a new CIBC Bancorp USA position in Q3 2025.
  • Amneal Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1306 holding.
  • 248 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.